Evidence map›Paper›PMID 34586754›Full record

Observational studyObesity (Silver Spring, Md.)2022

History of bariatric surgery and COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO study.

Claire Blanchard, Tanguy Perennec, Sarra Smati, Blandine Tramunt, Béatrice Guyomarch, Edith Bigot-Corbel, Lyse Bordier, Sophie Borot, Olivier Bourron, Cyrielle Caussy and 17 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Obesity (Silver Spring, Md.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 12 institutions in 1 country.

Claire BlanchardUniversité de Nantes, CHU Nantes, CNRS, INSERM, l'institut Du Thorax, Nantes, France.ORCID https://orcid.org/0000-0001-6801-7018
Tanguy PerennecCHU de Nantes, INSERM CIC 1413, Pôle Hospitalo-Universitaire 11 : Santé Publique, Clinique des données, Nantes, France.
Sarra SmatiUniversité de Nantes, CHU Nantes, CNRS, INSERM, l'institut Du Thorax, Nantes, France.
Blandine TramuntDépartement d'Endocrinologie, Diabétologie et Nutrition, CHU Toulouse, Institut des Maladies Métaboliques et Cardiovasculaires, UMR1297 INSERM/UPS, Université de Toulouse, Toulouse, France.
Béatrice GuyomarchUniversité de Nantes, CHU Nantes, CNRS, INSERM, l'institut Du Thorax, Nantes, France.
Edith Bigot-CorbelLaboratoire de Biochimie, CHU de Nantes, Hôpital G et R Laënnec, Nantes, France.
Lyse BordierHôpital d'instruction des Armées Bégin, Saint Mandé, France.
Sophie BorotDépartement d'Endocrinologie, Diabétologie et Nutrition, CHU de Besançon, Besançon, France.
Olivier BourronDépartement de Diabétologie, CHU La Pitié Salpêtrière-Charles Foix, Inserm, UMR_S 1138, Centre de Recherche des Cordeliers, Paris 06, Institute of Cardiometabolism and Nutrition ICAN, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France.
Cyrielle CaussyUniv-Lyon, laboratoire CarMeN, Inserm U1060, INRA U1397, Université Claude Bernard Lyon 1, INSA Lyon, Villeurbanne, France.ORCID https://orcid.org/0000-0001-8089-2907
Christine Coffin-BoutreuxDépartement d'Endocrinologie, Diabétologie, Maladies Métaboliques, CH de Périgueux, Périgueux, France.
Anne DutourAix Marseille Univ, APHM, INSERM, INRAE, C2VN, Hôpital Nord Département d'Endocrinologie et de Diabétologie, Marseille, France.
Natacha GermainDépartement d'Endocrinologie, CHU de Saint-Etienne, Saint-Etienne, France.
Céline Gonfroy-LeymarieService d'Endocrinologie, Diabétologie, CH de Pontoise, Pontoise, France.
Laurent MeyerDépartement d'Endocrinologie, Diabétologie et Nutrition, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Gaëtan PrevostDépartement d'Endocrinologie, Diabète et Maladies Métaboliques, Normandie Univ, UNIROUEN, CHU de Rouen, Rouen, France.
Ronan RousselDépartement d'Endocrinologie, Diabétologie et Nutrition, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Centre de Recherche des Cordeliers, INSERM, U-1138, Université de Paris, Paris, France.
Dominique Seret-BéguéService de Diabétologie, CH Gonesse, Gonesse, France.
Charles ThivoletCentre du Diabète DIAB-eCARE, Hospices Civils de Lyon, Lyon, France.
Bruno VergèsService Endocrinologie, Diabétologie et Maladies Métaboliques, Hôpital du Bocage, Dijon, France.
Matthieu PichelinUniversité de Nantes, CHU Nantes, CNRS, INSERM, l'institut Du Thorax, Nantes, France.
Pierre GourdyDépartement d'Endocrinologie, Diabétologie et Nutrition, CHU Toulouse, Institut des Maladies Métaboliques et Cardiovasculaires, UMR1297 INSERM/UPS, Université de Toulouse, Toulouse, France.
Samy HadjadjUniversité de Nantes, CHU Nantes, CNRS, INSERM, l'institut Du Thorax, Nantes, France.
Matthieu WargnyUniversité de Nantes, CHU Nantes, CNRS, INSERM, l'institut Du Thorax, Nantes, France.
François PattouUniv Lille, Inserm, CHU Lille, Institut Pasteur de Lille, European Genomic Institute of Diabetes, Chirurge Endocrinienne et Métabolique, Cente Intégré de l'Obésité, Lille, France.
Bertrand CariouUniversité de Nantes, CHU Nantes, CNRS, INSERM, l'institut Du Thorax, Nantes, France.
CORONADO investigators
Centre National de la Recherche Scientifique · FRInserm · FRUniversité Toulouse III - Paul Sabatier · FRBP (France) · FRCentre Hospitalier de Gonesse · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Saint-Étienne · FRHôpital d'Instruction des Armées Bégin · FRHôpitaux Universitaires de Strasbourg · FRHospices Civils de Lyon · FRNormandie Université · FRUniversité Claude Bernard Lyon 1 · FR

Funding

Fondation Francophone de Recherche sur le Diabète
6 · The paper itself

Abstract

objectiveThis study assessed the impact of a history of metabolic and bariatric surgery (MBS) on the clinical outcomes in patients with type 2 diabetes (T2D) and severe obesity hospitalized for COVID-19.

methodsIn this post hoc analysis from the nationwide observational CORONADO (Coronavirus SARS-CoV2 and Diabetes Outcomes) study, patients with T2D and a history of MBS were matched with patients without MBS for age, sex, and BMI either at the time of MBS or on admission for COVID-19. The composite primary outcome (CPO) combined invasive mechanical ventilation and/or death within 7 and 28 days following admission.

resultsOut of 2,398 CORONADO participants, 20 had a history of MBS. When matching for BMI at the time of MBS and after adjustment for diabetes duration, the CPO occurred less frequently within 7 days (3 vs. 17 events, OR: 0.15 [0.01 to 0.94], p = 0.03) and 28 days (3 vs. 19 events, OR: 0.11 [0.01 to 0.71], p = 0.02) in patients with MBS (n = 16) vs. controls (n = 44). There was no difference in CPO rate between patients with MBS and controls when matching for BMI on admission.

conclusionsThese data are reassuring regarding COVID-19 prognosis in patients with diabetes and a history of MBS compared with those without MBS.

Indexed as

Bariatric SurgeryCOVID-19Diabetes Mellitus, Type 2HumansRetrospective StudiesRNA, ViralSARS-CoV-2RNA, Viral

Identifiers

PMID34586754
PMCPMC8661775
OpenAlexW3202463375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.